Teleflex Saham

Teleflex Pendapatan per Saham

Pendapatan per Saham dari Teleflex (TFX) pada 24 Agu 2026 adalah 45,05 USD. Tahun sebelumnya, Pendapatan per Saham adalah 65,71 USD — perubahan sebesar -31,45% (lebih rendah).

Pendapatan per Saham

45,05USD

YoY

-31,45%

Terakhir Diperbarui:

Pendapatan per Saham dari Teleflex adalah 2026 45,05 USD. Pendapatan per Saham dari Teleflex adalah 2025 65,71 USD. Menurun -31,45% lebih rendah dibandingkan dengan tahun sebelumnya.

Sejarah Teleflex Pendapatan per Saham

  • 3 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

Pendapatan per Saham
Date
Pendapatan per Saham
1 Jan 2023
62,88 USD
1 Jan 2024
65,71 USD
1 Jan 2025
45,05 USD
1 Jan 2026 (e)
48,17 USD
1 Jan 2027 (e)
50,26 USD
1 Jan 2028 (e)
52,59 USD
1 Jan 2029 (e)
55,37 USD
1 Jan 2030 (e)
57,93 USD
Sejarah Teleflex Pendapatan per Saham
TAHUNPendapatan per SahamYoY
est57,93USD+4,63%
est55,37USD+5,29%
est52,59USD+4,63%
est50,26USD+4,35%
est48,17USD+6,93%
45,05USD-31,45%
65,71USD+4,50%
62,88USD+6,40%
59,10USD-0,26%
59,25USD+10,56%
53,59USD-2,52%
54,98USD+5,20%
52,26USD+13,56%
46,02USD+16,07%
39,65USD+5,88%
37,45USD-3,73%
38,90USD+3,28%
37,67USD+4,54%
36,03USD-3,92%
37,50USD-15,86%
44,57USD-5,21%
47,02USD-22,56%
60,71USD+24,63%
48,71USD-27,48%
67,17USD
Access this data via the Eulerpool API

Teleflex Analisis saham

Apa yang dilakukan Teleflex? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care. The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors. Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients. In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths. The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources. The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies. With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths. The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators. The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials. The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents. Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Teleflex

Pendapatan per Saham Teleflex adalah 45,05 USD pada tahun 2026.

Pendapatan per Saham dari Teleflex berubah dari 65,71 USD menjadi 45,05 USD, mewakili perubahan -31,45%. Nilainya lebih rendah daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Pendapatan per Saham Teleflex sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Pendapatan per Saham membagi total pendapatan dengan saham yang beredar, menunjukkan berapa banyak pendapatan yang diwakili setiap saham.

Access this data via the Eulerpool API

Laporan Laba Rugi — Teleflex

Semua Metrik Kunci — Teleflex